Managing Clinical Trials And Supply Amidst COVID-19 Outbreak
Source: Life Science Leader
Rob Wright, chief editor of Life Science Leader, conducted a virtual roundtable with CEOs of publicly traded biopharmaceutical companies (view full video here). In this clip, three CEOs provide perspective on the management of Wall St. expectations around clinical trials and supply amidst COVID-19 chaos.
Appearing in this video (in order) are:
- Bill Newell, J.D., CEO, Sutro Biopharma
- Karen Zaderej, CEO, AxoGen
- Mike Sherman, CEO, Chimerix
This website uses cookies to ensure you get the best experience on our website. Learn more